Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology
BioCentury This Week
00:00
The Supreme Court's Role in the Case of Miffa-Pristone
The fifth circuit tried to come up with a compromise but it doesn't actually make the situation any better either for abortion drug access or for the bigger issues about the integrity of the drug regulation process. The decision means that all of the drugs that they have out there on the market now are misbranded if the decision were to stay.
Transcript
Play full episode
